The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis
Open accessAbstract
Sarcopenia prevalence and its clinical impact are reportedly variable in chronic obstructive pulmonary disease (COPD) due partly to definition criteria. This review aimed to identify the criteria used to diagnose sarcopenia and the prevalence and impact of sarcopenia on health outcomes in people with COPD. This review was registered in PROSPERO (CRD42018092576). Five electronic databases were searched to August 2018 to identify studies related to sarcopenia and COPD. Study quality was assessed using validated instruments matched to study designs. Sarcopenia prevalence was determined using authors' definitions. Comparisons were made between people who did and did not have sarcopenia for pulmonary function, exercise capacity, quality of life, muscle strength, gait speed, physical activity levels, inflammation/oxidative stress, and mortality. Twenty‐three studies (70% cross‐sectional) from Europe (10), Asia (9), and North and South America (4) involving 9637 participants aged ≥40 years were included (69.5% men). Sarcopenia criteria were typically concordant with recommendations of hEuropean and Asian consensus bodies. Overall sarcopenia prevalence varied from 15.5% [95% confidence interval (CI) 11.8–19.1; combined muscle mass, strength, and/or physical performance criteria] to 34% (95%CI 20.6–47.3; muscle mass criteria alone) (P = 0.009 between subgroups) and was greater in people with more severe [37.6% (95%CI 24.8–50.4)] versus less severe [19.1% (95%CI 10.2–28.0)] lung disease (P = 0.020), but similar between men [41.0% (95%CI 26.2–55.9%)] and women [31.9% (95%CI 7.0–56.8%)] (P = 0.538). People with sarcopenia had lower predicted forced expiratory volume in the first second (mean difference −7.1%; 95%CI −9.0 to −5.1%) and poorer exercise tolerance (standardized mean difference −0.8; 95%CI −1.4 to −0.2) and quality of life (standardized mean difference 0.26; 95%CI 0.2–0.4) compared with those who did not (P < 0.001 for all). No clear relationship was observed between sarcopenia and inflammatory or oxidative stress biomarkers. Incident mortality was unreported in the literature. Sarcopenia is prevalent in a significant proportion of people with COPD and negatively impacts upon important clinical outcomes. Opportunities exist to optimize its early detection and management and to evaluate its impact on mortality in this patient group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 6×
“The most commonly used criteria were those of Newman et al.54 and Baumgartner et al.,55 which are also considered by the EWGSOP.7 Borda et al.29 measured muscle mass with calf circumference, which confers simplicity as a screening method for sarcopenia,56,57 but it is not recommended.7,15,19,43,49 Similar advice is al…”
BackgroundMethodInfluentialATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 1×
“measured muscle mass with calf circumference, which confers simplicity as a screening method for sarcopenia,(56,57) but it is not recommended.(7,15,19,43,49) Similar advice is also available for the assessment of muscle strength (handgrip force) and physical performance (gait speed),(7,15) yet inconsistencies were aga…”
BackgroundImproved Docking of Polypeptides with Glide
Tubert-Brohman, I., Sherman, W., Repasky, M., & Beuming, T. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400128m · Cited by 1,308
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.-Y., & Bruyère, O. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169548 · Cited by 1,272
Sarcopenia with limited mobility: an international consensus
Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos, V., Bauer, J., Bhasin, S., Cederholm, T., Stewart Coats, A. J., Cummings, S. R., Evans, W. J., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.04.014 · Cited by 1,125
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Sarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981
Clark, B. C., & Manini, T. M. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.8.829 · Cited by 835
Oxidative Stress, Molecular Inflammation and Sarcopenia
Meng, S.-J., & Yu, L.-J. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041509 · Cited by 637
Evans, W. J. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.5 · Cited by 606
Sarcopenia, Calf Circumference, and Physical Function of Elderly Women: A Cross‐Sectional Study
Rolland, Y., Lauwers‐Cances, V., Cournot, M., Nourhashémi, F., Reynish, W., Rivière, D., Vellas, B., & Grandjean, H. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51362.x · Cited by 509
Mayhew, A. J., Amog, K., Phillips, S., Parise, G., McNicholas, P. D., de Souza, R. J., Thabane, L., & Raina, P. (2019) · Age and Ageing · doi:10.1093/ageing/afy106 · Cited by 478
Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation
Jones, S. E., Maddocks, M., Kon, S. S. C., Canavan, J. L., Nolan, C. M., Clark, A. L., Polkey, M. I., & Man, W. D.-C. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206440 · Cited by 435
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019
von Haehling, S., Morley, J. E., Coats, A. J. S., & Anker, S. D. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12501 · Cited by 389
Sarcopenia and mortality among a population‐based sample of community‐dwelling older adults
Brown, J. C., Harhay, M. O., & Harhay, M. N. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12073 · Cited by 354
Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
Maddocks, M., Kon, S. S. C., Canavan, J. L., Jones, S. E., Nolan, C. M., Labey, A., Polkey, M. I., & Man, W. D.-C. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-208460 · Cited by 314
Sarcopenia and frailty in chronic respiratory disease: Lessons from gerontology
Bone, A. E., Hepgul, N., Kon, S., & Maddocks, M. (2017) · Chronic Respiratory Disease · doi:10.1177/1479972316679664 · Cited by 309
Toy, E. L., Gallagher, K. F., Stanley, E. L., Swensen, A. R., & Duh, M. S. (2010) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.481697 · Cited by 247
Improvements in the StArt tool to better support the systematic review process
Fabbri, S., Silva, C., Hernandes, E., Octaviano, F., Di Thommazo, A., & Belgamo, A. (2016) · Proceedings of the 20th International Conference on Evaluation and Assessment in Software Engineering · doi:10.1145/2915970.2916013 · Cited by 226
Simple functional performance tests and mortality in COPD
Puhan, M. A., Siebeling, L., Zoller, M., Muggensturm, P., & ter Riet, G. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131612 · Cited by 208
Sarcopenia correlates with systemic inflammation in COPD
Byun, M. K., Cho, E. N., Chang, J., Ahn, C. M., & Kim, H. J. (2017) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s130790 · Cited by 204
Kim, S. Y., Kim, M., Lee, Y., Kim, B.-S., Yoon, T., & Won, C. W. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e151 · Cited by 161
The modified BODE index: validation with mortality in COPD
Côté, C., Pinto-Plata, V., Marín, J. M., Nekach, H., Dordelly, L. J., & Celli, B. R. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138507 · Cited by 152
Developing Consensus Criteria for Sarcopenia: An Update
McLean, R. R., & Kiel, D. P. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2492 · Cited by 151
Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations
Vilaró, J., Ramírez-Sarmiento, A., Martínez‐Llorens, J., Mendoza, T., Álvarez, M. A. L., Sánchez-Cayado, N., Vega, Á., Gimeno, E., Coronell, C., Gea, J., et al. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.05.001 · Cited by 145
Zinellu, E., Zinellu, A., Fois, A. G., Carru, C., & Pirina, P. (2016) · Respiratory Research · doi:10.1186/s12931-016-0471-z · Cited by 144
Problematic Activities of Daily Life are Weakly Associated With Clinical Characteristics in COPD
Annegarn, J., Meijer, K., Passos, V. L., Stute, K., Wiechert, J., Savelberg, H. H. C. M., Schols, A. M. W. J., Wouters, E. F. �., & Spruit, M. A. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.002 · Cited by 143
Sarcopenia in COPD: relationship with COPD severity and prognosis
Costa, T. M. D. R. L., Costa, F. M., Moreira, C. A., Rabelo, L. M., Boguszewski, C. L., & Borba, V. Z. C. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000000040 · Cited by 129
Joppa, P., Tkáčová, R., Franssen, F. M. E., Hanson, C., Rennard, S. I., Silverman, E. K., McDonald, M., Calverley, P. M. A., Tal‐Singer, R., Spruit, M. A., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.03.020 · Cited by 128
Sergi, G., Coin, A., Marín, S., Vianello, A., Manzan, A., Peruzza, S., Inelmen, E. M., Busetto, L., Mulone, S., & Enzi, G. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.03.008 · Cited by 118
de Blasio, F., Gregorio, A. D., Blasio, F. D., Bianco, A., Bellofiore, B., & Scalfi, L. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.11.006 · Cited by 113
Andrianopoulos, V., Wouters, E. F. �., Pinto-Plata, V., Vanfleteren, L. E. G. W., Bakke, P. S., Franssen, F. M. E., Agustí, A. G. N., MacNee, W., Rennard, S. I., Tal‐Singer, R., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.06.013 · Cited by 111
Evaluation of Quality of Life instruments for use in COPD care and research: A systematic review
Weldam, S. W. M., Schuurmans, M. J., Liu, R., & Lammers, J. J. (2012) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2012.07.017 · Cited by 100
Blasi, F., Cesana, G., Conti, S., Chiodini, V., Aliberti, S., Fornari, C., & Mantovani, L. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101228 · Cited by 92
Jackson, M. J. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.05.002 · Cited by 88
Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD
van de Bool, C., Rutten, E. P. A., Franssen, F. M. E., Wouters, E. F. �., & Schols, A. M. W. J. (2015) · European Respiratory Journal · doi:10.1183/09031936.00197314 · Cited by 86
GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway
Leivseth, L., Brumpton, B. M., Nilsen, T. I. L., Mai, X., Johnsen, R., & Langhammer, A. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203270 · Cited by 86
Limpawattana, P., Inthasuwan, P., Putraveephong, S., Boonsawat, W., Theerakulpisut, D., & Sawanyawisuth, K. (2017) · Chronic Respiratory Disease · doi:10.1177/1479972317743759 · Cited by 85
Treatable traits in acute exacerbations of chronic airway diseases
McDonald, V. M., Osadnik, C. R., & Gibson, P. G. (2019) · Chronic Respiratory Disease · doi:10.1177/1479973119867954 · Cited by 83
Self-citationBak, S. H., Kwon, S. O., Han, S., & Kim, W. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-1191-y · Cited by 81
Altered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary disease
Ahmad, A., Shameem, M., & Husain, Q. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0512 · Cited by 78
Role of Exercise and Nutrition in the Prevention of Sarcopenia
Makanae, Y., & Fujita, S. (2015) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.61.s125 · Cited by 78
Chest computed tomography-derived low fat-free mass index and mortality in COPD
McDonald, M., Díaz, A. A., Rutten, E. P. A., Lutz, S. M., Harmouche, R., Estépar, R. S. J., Kinney, G. L., Hokanson, J. E., Gower, B. A., Wouters, E. F. �., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01134-2017 · Cited by 78
Body composition and sarcopenia in patients with chronic obstructive pulmonary disease
Costa, T. M. D. R. L., Costa, F. M., Jonasson, T. H., Moreira, C. A., Boguszewski, C. L., & Borba, V. Z. C. (2018) · Endocrine · doi:10.1007/s12020-018-1533-4 · Cited by 68
Pectoralis muscle area and mortality in smokers without airflow obstruction
Díaz, A. A., Martinez, C. H., Harmouche, R., Young, T. P., McDonald, M., Ross, J. C., Han, M. L. K., Bowler, R. P., Make, B. J., Regan, E. A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0771-6 · Cited by 67
Martínez-Amat, A., Aibar-Almazán, A., Fábrega-Cuadros, R., Cruz-Díaz, D., Jiménez-García, J. D., Pérez-López, F. R., Achalandabaso, A., Barranco-Zafra, R., & Hita-Contreras, F. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.02.005 · Cited by 65
The Relation between Sarcopenia and Mortality in Patients at Intensive Care Unit
Toptaş, M., Yalçın, M., Akkoç, İ., Demir, E., Metin, C., Savaş, Y., Kalyoncuoğlu, M., & Can, M. M. (2018) · BioMed Research International · doi:10.1155/2018/5263208 · Cited by 64
Frailty syndrome in ambulatory patients with COPD
Limpawattana, P., Putraveephong, S., Inthasuwan, P., Boonsawat, W., Theerakulpisut, D., & Chindaprasirt, J. (2017) · International Journal of COPD · doi:10.2147/copd.s134233 · Cited by 63
Kim, M. S., Lim, N. G., Kim, H. J., Kim, C. H., & Lee, J. Y. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e1 · Cited by 61
Kneppers, A. E. M., Langen, R. C. J., Gosker, H. R., Verdijk, L. B., Cebron Lipovec, N., Leermakers, P. A., Kelders, M. C. J. M., de Theije, C. C., Omersa, D., Lainscak, M., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.04.016 · Cited by 55
Koo, H., Joo-Hyun, P., Park, H. K., Jung, H., & Lee, S.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110448 · Cited by 50
Muscle Quality is More Impaired in Sarcopenic Patients With Chronic Obstructive Pulmonary Disease
van de Bool, C., Gosker, H. R., van den Borst, B., den Kamp, C. M. O., Slot, I. G. M., & Schols, A. M. W. J. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.12.094 · Cited by 50
Lipovec, N. Č., Schols, A. M. W. J., van den Borst, B., Beijers, R. J. H. C. G., Kosten, T., Omersa, D., & Lainščak, M. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.05.002 · Cited by 46
Chung, J. H., Hwang, H., Han, C. H., Son, B. S., Kim, D. H., & Park, M. S. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.908835 · Cited by 43
Clinical Implications of Sarcopenia on Decreased Bone Density in Men With COPD
Hwang, J. A., Kim, Y. S., Leem, A. Y., Park, M. S., Kim, S. I., Chang, J., & Jung, J. Y. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.12.006 · Cited by 39
Sanders, K. J. C., Degens, J. H. R. J., Dingemans, A. C., & Schols, A. M. W. J. (2019) · International Journal of COPD · doi:10.2147/copd.s194003 · Cited by 39
Body composition in patients with chronic obstructive pulmonary disease.
Gologanu, D. S., Ionita, D. L., Gartonea, T., Stanescu, C. M., & Bogdan, M. A. (2014) · PubMed · Cited by 37
Lee, D.-W., & Choi, E.-Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164303 · Cited by 34
Pothirat, C., Chaiwong, W., Phetsuk, N., Liwsrisakun, C., Bumroongkit, C., Deesomchok, A., Theerakittikul, T., & Limsukon, A. (2016) · PubMed · Cited by 26
Lee, D.-W., Jin, H. J., Shin, K., Chung, J.-H., Lee, H.-W., & Lee, K. H. (2017) · International Journal of COPD · doi:10.2147/copd.s138497 · Cited by 19
Severely Decreased Muscle Mass among Older Patients Hospitalized in a Long-Term Care Ward in Japan
Yamanouchi, A., Yoshimura, Y., Matsumoto, Y., & Jeong, S. (2016) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.62.229 · Cited by 15
Mecanismos fisiopatológicos de la sarcopenia en la EPOC
Sepúlveda‐Loyola, W., Sergio, P., & Probst, V. S. (2019) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482019000200124 · Cited by 15
Self-citationScarlata, S., Cesari, M., & Incalzi, R. A. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-206929 · Cited by 11
Cited by
Casey, P., Alasmar, M., McLaughlin, J., Ang, Y., McPhee, J., Heire, P., & Sultan, J. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13041 · Cited by 164
Persson, H. L., Sioutas, A., Kentson, M., Jacobson, P., Lundberg, P., Dahlqvist Leinhard, O., & Forsgren, M. F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s366204 · Cited by 25
Zhang, L., Li, D., Chang, C., & Sun, Y. (2022) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s377226 · Cited by 22
Metadata
- Authors
- Sepúlveda‐Loyola, W., Osadnik, C., Phu, S., Morita, A. A., Duque, G., & Probst, V. S.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2020-08-30
- Volume
- 11
- Issue
- 5
- Pages
- 1164-1176
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W3081708742
- Cited by
- 297
- References
- 71
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.